Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton

Size: px
Start display at page:

Download "Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton"

Transcription

1 Future of the Project BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton

2 What were goals of BioMedBridges? GOAL 1: To provide computational data and service bridges between the BMS RIs, linking basic biological research and data to clinical research and associated data

3 26 tools and services produced or extended within BioMedBridges WebMicroscope Ontology Tree Viewer MetalPDB AMPS-NMR Bigr XNAT, XNAT MetalS2 MaxOcc Clinical Trials Information Mediator Online Dictionary of common molecular identifiers myequivalents Shape Matching Tool GenoBridge BBMRI-EU catalog BBMRI-Portal MousePhenotype Legal and ethics tool Tools and Services Registry MOLGENIS, MOLGENIS compute Metadata Model and Mapping Registry PIMS, PiMS LIMS FindGeo BBMRI-NL catalog

4 Collaborative tools: Links for the future Common tools and services for data integration Lines indicate tools that are either co-developed or link pairs of RIs Thicker lines = larger number of common tools third generation RIs are now well integrated!

5 What were goals of BioMedBridges? To provide secure, robust and ethical access to data for a wide range of users: Legal Assessment Tool - LAT Security Framework Ethics framework

6 What were goals of BioMedBridges? To allow interoperability between data and services in the biological, medical, translational and clinical domains Examples Biomedical data tools to allow integration of biomedical image XNAT data into TransMart (infrastructure currently used for omics data patient-to-bench ) Improving access to biobanks and their data, plus integration with public data Diabetes ontology (mouse & human) UniChem links chemical biology resources

7 CHALLENGES Communication between RIs (technical and social) Involvement of relevant community (eg to adopt an ontology); clinicians Engagement with other members of ESFRI infrastructures Coverage space is vast and sometimes overwhelming; BMB can only contribute drops in the ocean but these can be the acorns from which big trees grow.

8 What were goals of BioMedBridges? To bring together the ESFRI BMS RIs with the European computer hardware e-infrastructures: GÉANT, DANTE, EGI, PRACE & CERN:- Developed links to EGI & EUDAT Links to CERN Usage of Geant Better contacts with e-infrastructures

9 STILL to COME! Within BMB Completion of major components of BMB Open Bridges Symposium Future Initiatives (ESFRIs et al) Basis for the future Quantitative Clinical Medicine Multiscale analysis from molecules to organisms Tracking biodiversity Mining of Big Data Translational Research

10 Sustainability Many WPs have a preliminary plan for sustainability, but details need to be worked out Mainly through relevant ESFRI, but also through other established routes e.g. CCP-EM Funding not always available Sustainability is easier if there is a large, involved user and developer community

11 Sustainability and Reuse Visualising and leveraging ontologies in queries Sharing and integrating medical imaging data Reuse CTTV, Euro- BioImaging CTMM-TRAIT Source code Hosting Bug fixes New features Expertise Funding Knowledge/ docume ntation Licenses Integrating mouse phenotype data for studying diabetes and obesity CTTV Sharing protein engineering knowledge Federating biobank queries for translational research CTTV Biosample information integration and discovery CTTV Leveraging the utility of compound screening functional assays CTTV Connectivity-Based searching in UniChem CTTV Connect clinical and lab workflows using TranSMART, Galaxy CTMM-TRAIT Linking clinical trials to the drugs, genes, and results they reference?

12 IMPACT Built bridges between the BMS RIs Established collaborations between RIs on the technical level Raised visibility of BMS RIs as a community Increased collaborations with the e-infrastructures Raised awareness, understanding and expertise of the strategic importance of data and related issues, within RIs Sown the seeds for future better integration between biological Highlighted the data challenges and identified priority areas in need of urgent attention

13 Lessons Learned One size does not fit all The use cases are really valuable at the beginning to influence the development of tools Integration with global efforts is essential Legal issues are difficult and changing Not always a single solution - Solutions evolve Dissemination and user engagement remains a challenge

14 BioMedBridges Open Symposium November 2015, Genome Campus, Hinxton Open meeting hosted by ELIXIR, up to 300 delegates Room for workshops: BioMedBridges and BMS RIs Still lots of room available! Sponsor exhibition/ poster session/ dinner?

15 External speakers Confirmed speakers include: Phil Bourne, NIH: Open data in a global ecosystem Helen Firth, University of Cambridge: Deciphering Developmental Disorders Peter Luijten, University of Utrecht: The role of imaging in translational research Ruth March, Astra Zeneca: How the big data explosion is transforming pharma ESFRI Representation BOTTLE OF CHAMPAGNE FOR BEST REPRESENTED ESFRI (Excluding ELIXIR) Parallel workshops BMS RIs and relevant external initiatives and organisations

Computational Challenges in Life Sciences Research Infrastructures

Computational Challenges in Life Sciences Research Infrastructures Computational Challenges in Life Sciences Research Infrastructures Alvis Brazma European Bioinformatics Institute European Molecular Biology Laboratory European Bioinformatics Institute (EBI) EBI is in

More information

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI Interpreting Genome Data for Personalised Medicine Professor Dame Janet Thornton EMBL-EBI Deciphering a genome 3 billion bases 4 million variants 21,000 coding variants 10,000 non-synonymous variants 50-100

More information

TraIT Foundation - governance in cloud applications

TraIT Foundation - governance in cloud applications TraIT Foundation - governance in cloud applications SURF Life Science Seminar - 12 / 10 / 2018 Rita Azevedo Lygature - Utrecht, rita.azevedo@lygature.org TraIT Translational Research IT Sustainable infrastructure

More information

WP8 Status update. Henrik Edgren on behalf of WP8 (EBI, KI, UDUS, TUM-MED, UH) First BioMedBridges Annual General Meeting March 2013, Düsseldorf

WP8 Status update. Henrik Edgren on behalf of WP8 (EBI, KI, UDUS, TUM-MED, UH) First BioMedBridges Annual General Meeting March 2013, Düsseldorf WP8 Status update Henrik Edgren on behalf of WP8 (EBI, KI, UDUS, TUM-MED, UH) First BioMedBridges Annual General Meeting 11-12 March 2013, Düsseldorf PM use case The PM project is a collaboration between

More information

A framework for quality management in the biomedical research infrastructures (BMS RIs)

A framework for quality management in the biomedical research infrastructures (BMS RIs) Common BMS RI Framework for Quality Management A framework for quality management in the biomedical research infrastructures (BMS RIs) BMS RIs put quality at the heart of biomedical research It has been

More information

How can we build a strong and thriving open source / open data community around FAIR principles?

How can we build a strong and thriving open source / open data community around FAIR principles? How can we build a strong and thriving open source / open data community around FAIR principles? PERSONAL HEALTH TRAIN WORKSHOP, UTRECHT, NOVEMBER 10, 2016 Kees van Bochove, CEO & Founder, The Hyve Agenda

More information

Coordinated Research Infrastructures Building Enduring Life science services

Coordinated Research Infrastructures Building Enduring Life science services www.corbel project.eu Coordinated Research Infrastructures Building Enduring Life science services Or as I call it: a perfect playground for DTL BACKGROUND: EUROPE IS INVESTING IN RESEARCH INFRASTRUCTURES

More information

Bridging the Gap Between Basic and Clinical Research. Julio E. Celis Danish Cancer Society

Bridging the Gap Between Basic and Clinical Research. Julio E. Celis Danish Cancer Society Bridging the Gap Between Basic and Clinical Research Julio E. Celis Danish Cancer Society Barriers and Oportunities in Translational Research Promise of the new technologies What is Europe doing? Challenges

More information

Powering Translational Medicine with Semantic Web technologies

Powering Translational Medicine with Semantic Web technologies Powering Translational Medicine with Semantic Web technologies Michel Dumontier, Ph.D. Associate Professor of Medicine (Biomedical Informatics) Stanford University 1 Outline reproducible science linked

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

Nordic Register and Biobank Data

Nordic Register and Biobank Data Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016 Nordic

More information

Von Mäusen und Menschen Datenbrücken verbessern den Zugang zu Forschungsdaten in INFRAFRONTIER

Von Mäusen und Menschen Datenbrücken verbessern den Zugang zu Forschungsdaten in INFRAFRONTIER Von Mäusen und Menschen Datenbrücken verbessern den Zugang zu Forschungsdaten in INFRAFRONTIER Michael Raess & Philipp Gormanns, Helmholtz Zentrum München Helmholtz Open Access Webinars 16 and 24 July

More information

Galaxy and transmart in data management in translational research

Galaxy and transmart in data management in translational research Galaxy and transmart in management in translational research Remond Fijneman, Mariska Bierkens, Sanne Abeln, Jan-Willem Boiten r.fijneman@nki.nl Galaxy and transmart in management in translational research

More information

Elixir: European Bioinformatics Research Infrastructure. Rolf Apweiler

Elixir: European Bioinformatics Research Infrastructure. Rolf Apweiler Elixir: European Bioinformatics Research Infrastructure Rolf Apweiler EMBL-EBI Service Mission To enable life science research and its translation to medicine, agriculture, the bioindustries and society

More information

David Wild Indiana University Bloomington & Data2Discovery Inc

David Wild Indiana University Bloomington & Data2Discovery Inc David Wild Indiana University Bloomington & Data2Discovery Inc Graduate program director, Data Science & Cheminformatics IU IDSL- CCRG group researches semantic methods in drug discovery (and beyond) Chem2Bio2RDF

More information

Ethical Governance Framework

Ethical Governance Framework Ethical Governance Framework Version 1.1, April 2013 1 of 18 Contents Contents... 2 Definition of terms used in this document... 3 1 Introduction... 5 1.1 Project aims... 5 1.2 Background for the Ethical

More information

Semantic Enrichment and the Information Manager

Semantic Enrichment and the Information Manager WHITEPAPER Semantic Enrichment and the Information Manager Turning Content into Insight It is more resource intensive to bring a drug to market than ever before: Pharmaceutical companies spend an average

More information

TraIT Multimodal data management

TraIT Multimodal data management TraIT Multimodal data management Data management in clinical research 2018-11-15 Rita Azevedo Lygature - Utrecht, rita.azevedo@lygature.org Portugal International Collaboration and Multimodal Experience

More information

Developments in BioPharma Grid Computing. Rowan Gardner, BioLauncher Ltd

Developments in BioPharma Grid Computing. Rowan Gardner, BioLauncher Ltd Developments in BioPharma Grid Computing Rowan Gardner, BioLauncher Ltd PharmaGRID 2004 60 Delegates, a beautiful location, good food and excellent speakers Speakers Prof. Denis Noble, Applications in

More information

Fundamentals of Clinical Genomics

Fundamentals of Clinical Genomics Fundamentals of Clinical Genomics Wellcome Genome Campus Hinxton, Cambridge, UK 17-19 January 2018 Lectures and Workshops to be held in the Rosalind Franklin Pavilion Lunch and Dinner to be held in the

More information

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Interview Maximizing the Value of Biospecimens to Deliver New Therapies with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Introduction and Background CLIVE GREEN This ebook originated

More information

EGI-Engage: The AAI Strategy for the EGI Infrastructure

EGI-Engage: The AAI Strategy for the EGI Infrastructure EGI-Engage: The AAI Strategy for the EGI Infrastructure Christos Kanellopoulos - GRNET www.egi.eu EGI-Engage is co-funded by the Horizon 2020 Framework Programme of the European Union under grant number

More information

Translational Research

Translational Research Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic

More information

EU Big Data Initiatives

EU Big Data Initiatives European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives

More information

Can Semantic Web Technologies enable Translational Medicine? (Or Can Translational Medicine help enrich the Semantic Web?)

Can Semantic Web Technologies enable Translational Medicine? (Or Can Translational Medicine help enrich the Semantic Web?) Can Semantic Web Technologies enable Translational Medicine? (Or Can Translational Medicine help enrich the Semantic Web?) Vipul Kashyap 1, Tonya Hongsermeier 1, Samuel Aronson 2 1 Clinical Informatics

More information

Biomedical Informatics in BIG DATA Era

Biomedical Informatics in BIG DATA Era Biomedical Informatics in BIG DATA Era Yang C. Fann, Ph.D. Director, Intramural IT and Bioinformatics Program National Institute of Neurological Disorders and Stroke Disclaimer The opinions or assertions

More information

Innovative Medicines Initiative Sadallah Fatiha IMI JU Office, Brussels, Belgium

Innovative Medicines Initiative Sadallah Fatiha IMI JU Office, Brussels, Belgium Innovative Medicines Initiative 2 2009-2014 Sadallah Fatiha IMI JU Office, Brussels, Belgium The Evolution of IMI: From bottlenecks in industry to bottlenecks in Industry and Society Make Drug R&D processes

More information

Data Science at the UNC Eshelman School of Pharmacy

Data Science at the UNC Eshelman School of Pharmacy Data Science at the UNC Eshelman School of Pharmacy Alexander Tropsha Associate Dean for Pharmacoinformatics and Data Science UNC Eshelman School of Pharmacy University of North Carolina, Chapel Hill,

More information

Maria Anvret, Vice- chair of Health and Food Strategy Working Group

Maria Anvret, Vice- chair of Health and Food Strategy Working Group Maria Anvret, Vice- chair of Health and Food Strategy Working Group 2017 Málaga Spain Health and Food Sector The economic impact of investments in large- scale biomedical research, e.g. 3.75 bn investment

More information

4 th ESPT SUMMER SCHOOL

4 th ESPT SUMMER SCHOOL 4 th ESPT SUMMER SCHOOL PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you to the 4th ESPT

More information

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through

More information

The Wonderful World of Informatics

The Wonderful World of Informatics The Wonderful World of Informatics VI Jornadas Universitarias de Sistemas de Informción en Salud 31 de octubre, 1 y 2 de noviembre 2011 W. Ed Hammond, PhD, FACMI, FAIMI, FAIMBE, FHL7 Director, Duke Center

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/6/242/242cm6/dc1 Supplementary Materials for Sandbox: Building and Sharing Resources This PDF file includes: Mark David Lim E-mail: mlim@fastercures.org

More information

EMMA - European Mouse Mutant Archive Michael Hagn

EMMA - European Mouse Mutant Archive Michael Hagn EMMA - European Mouse Mutant Archive Michael Hagn EMMA - European Mouse Mutant Archive OVERVIEW EMMA objectives EMMA network EMMA archive statistics EMMA projects Infrafrontier Key Objectives of EMMA Archiving

More information

Open Innovation March 2014

Open Innovation March 2014 Open Innovation March 2014 Open innovation Necessity is the mother of all invention English Proverb ascribed to Plato. Is Open Innovation an idea born out of necessity to survive for big Pharma? Open innovation

More information

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives European Genome phenome Archive at the European Bioinformatics Institute Helen Parkinson Head of Molecular Archives What is EMBL-EBI? International, non-profit research institute Part of the European Molecular

More information

Short Course Instructors

Short Course Instructors Short Course Instructors Andrew Allen, Ph.D., Professor of Biostatistics and Bioinformatics and Director of the new Duke Center of Statistical Genetics and Genomics, Duke University, has expertise in statistical

More information

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary

More information

Scientific Advisory Board. Report of the first meeting

Scientific Advisory Board. Report of the first meeting Scientific Advisory Board Report of the first meeting Utrecht, The Netherlands, May 15 and 16, 2017 1 1) Introduction With this document, the Scientific Advisory Board reports on its discussions held in

More information

Overview: Towards a European open source knowledge management infrastructure. Scott Wagers, MD BioSci Consulting

Overview: Towards a European open source knowledge management infrastructure. Scott Wagers, MD BioSci Consulting Overview: Towards a European open source knowledge management infrastructure Scott Wagers, MD BioSci Consulting Innovative Medicines Initiative: Joining Forces in the Healthcare Sector U-BIOPRED Annual

More information

Parallel Scientific Advice- TLV s perspective. Wing Cheng DIA Euromeeting Vienna 26th March 2014

Parallel Scientific Advice- TLV s perspective. Wing Cheng DIA Euromeeting Vienna 26th March 2014 Parallel Scientific Advice- TLV s perspective Wing Cheng DIA Euromeeting Vienna 26th March 2014 Overview History: Pilot project TLV-MPA National advice process TLVs experience: EMA-HTA and EUnetHTA Comparison

More information

Introduction to EMBL-EBI.

Introduction to EMBL-EBI. Introduction to EMBL-EBI www.ebi.ac.uk What is EMBL-EBI? Part of EMBL Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands,

More information

Bioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012

Bioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012 Bioinformatics: Present & Future from an EBI Perspective Janet Thornton UCL February 14 th 2012 What is bioinformatics? The science of storing, retrieving and analysing large amounts of biological information

More information

Grand Challenges: Research infrastructures at the forefront

Grand Challenges: Research infrastructures at the forefront Translational Research and Clinical Trials Grand Challenges: Research infrastructures at the forefront ICRI Copenhagen 2012 Prof. Dr. Liselotte Højgaard, MD DMSc Chair EMRC, The European Medical research

More information

The EORTC Molecular Screening programme SPECTA

The EORTC Molecular Screening programme SPECTA The EORTC Molecular Screening programme SPECTA February 2016 Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium The changing shape of clinical research Phase I RESOURCES Phase III The changing

More information

European Induced Pluripotent Stem Cell Bank

European Induced Pluripotent Stem Cell Bank European Induced Pluripotent Stem Cell Bank Background Researchers are looking for ways to validate pathways using human data. ips cells are one approach to this. ips research and banking is fragmented

More information

Meeting report series. Report of the 4th Therapies Scientific Committee Meeting

Meeting report series. Report of the 4th Therapies Scientific Committee Meeting Meeting report series Report of the 4th Therapies Scientific Committee Meeting 24 January Organization Organized by: Scientific Secretariat Participants Yann Le Cam, Paris, France (Chair) Dr Adam Heathfield,

More information

PATIENT STRATIFICATION. 15 year A N N I V E R S A R Y. The Life Sciences Knowledge Management Company

PATIENT STRATIFICATION. 15 year A N N I V E R S A R Y.   The Life Sciences Knowledge Management Company PATIENT STRATIFICATION Treat the Individual with the Knowledge of All BIOMAX 15 year A N N I V E R S A R Y The Life Sciences Knowledge Management Company Patient Stratification Tailoring treatment of the

More information

Recent years have witnessed an expansion in the disciplines encompassing drug

Recent years have witnessed an expansion in the disciplines encompassing drug Course overview Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of Universities

More information

The International Consortium for Personalised Medicine

The International Consortium for Personalised Medicine The International Consortium for Personalised Medicine Mairead O Driscoll Alliance for Biomedical Research in Europe, 8 November 2017 Personalised Medicine A definition Characterisation of individuals

More information

Antibody Discovery at Evotec

Antibody Discovery at Evotec Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic

More information

The Need for Scientific. Data Annotation. Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences.

The Need for Scientific. Data Annotation. Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences. The Need for Scientific Data Annotation Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences alaw@us.ibm.com Cross disciplinary research approach requires organizations to address diverse needs

More information

Smart India Hackathon

Smart India Hackathon TM Persistent and Hackathons Smart India Hackathon 2017 i4c www.i4c.co.in Digital Transformation 25% of India between age of 16-25 Our country needs audacious digital transformation to reach its potential

More information

Proof of Concept. Achieve your molecule s full potential

Proof of Concept. Achieve your molecule s full potential Proof of Concept Achieve your molecule s full potential Table of contents 01 Maximize the value of your molecule 02 Enhance your resources and 03 Increase your speed and efficiency 04 your product s market

More information

THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH

THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH Georges De Moor EuroRec, Ghent University Electronic Health Records for Clinical Research 192 Growing number of Participating Projects

More information

Agenda. Machado) v biocaddie Supplement Proposals (Ohno- v Project Team Report (Hagstrom) v Technical Team Report (Xu, Farcas, Grethe)

Agenda. Machado) v biocaddie Supplement Proposals (Ohno- v Project Team Report (Hagstrom) v Technical Team Report (Xu, Farcas, Grethe) Agenda biocaddie Supplement Proposals (Ohno- Machado) Project Team Report (Hagstrom) Technical Team Report (Xu, Farcas, Grethe) Working Groups Report Project Plan Review 1 SUPPLEMENT PROPOSALS (Ohno-Machado)

More information

Delivering the NIHR Central Commissioning Facility

Delivering the NIHR Central Commissioning Facility Delivering the NIHR Central Commissioning Facility About the NIHR The National Institute for Health Research is funded through the Department of Health to improve the health and wealth of the nation through

More information

Biomarkers as an emerging growth area in Denmark

Biomarkers as an emerging growth area in Denmark Biomarkers as an emerging growth area in Denmark International Conference on Perspectives in Precision Medicine, Copenhagen March 1, 2018 Kim Holmstrøm, PhD. Chairman of The Danish Biomarker Network R&D

More information

4 th ESPT SUMMER SCHOOL

4 th ESPT SUMMER SCHOOL 4 th ESPT SUMMER SCHOOL SUPPORTED BY SPHN PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you

More information

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005 Bioinformatics is the recording, annotation, storage, analysis, and searching/retrieval of nucleic acid sequence (genes and RNAs), protein sequence and structural information. This includes databases of

More information

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International

More information

TEXT MINING: THE NEXT DATA FRONTIER

TEXT MINING: THE NEXT DATA FRONTIER TEXT MINING: THE NEXT DATA FRONTIER An infrastructural approach for mining scientific content Natalia Manola Athena Research & Innovation Center OpenMinTeD OUTLINE Text mining on scientific content What

More information

Data representation for clinical data and metadata

Data representation for clinical data and metadata Data representation for clinical data and metadata WP1: Data representation for clinical data and metadata Inconsistent terminology creates barriers to identifying common clinical entities in disparate

More information

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 FNR Overview of the Luxembourg biomedical and health research ecosystem FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 Research in Luxembourg Luxembourg : a young research location Creating structures

More information

Advancing Clinical and Translational Research with HERON at the University of Kansas Medical Center

Advancing Clinical and Translational Research with HERON at the University of Kansas Medical Center Advancing Clinical and Translational Research with HERON at the University of Kansas Medical Center Russ Waitman, PhD Director of Medical Informatics, Associate Professor, Department of Biostatistics Director,

More information

Big Data Standards and the Potential Long-Term Benefits for Research and Clinical Development

Big Data Standards and the Potential Long-Term Benefits for Research and Clinical Development Big Data Standards and the Potential Long-Term Benefits for Research and Clinical Development Eric Engelhard, Ph.D. Director of Informatics Mouse Biology Program UC Davis ekengelhard@ucdavis.edu UC Davis

More information

The Irish Biomarker Network - Inaugural Workshop Improved Translation of Biomarkers to the Clinic

The Irish Biomarker Network - Inaugural Workshop Improved Translation of Biomarkers to the Clinic The Irish Biomarker Network - Inaugural Workshop Improved Translation of Biomarkers to the Clinic 1 The Irish Biomarker Network -Inaugural Workshop Improved Translation of Biomarkers to the Clinic Overview

More information

Quo vadis Medical Industry?

Quo vadis Medical Industry? Quo vadis Medical Industry? 18th December 2014 Karl Branzén Sweden has experienced the winds of change in the drug industry In the 70s and 80s Sweden had two big medical/drug corporations Pharmacia and

More information

MediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd

MediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd 4th of November 2014 MediSapiens Ltd Because data is not knowledge Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2014 MediSapiens Ltd. All rights reserved. medisapiens.com MediSapiens Brief

More information

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs

More information

October, Integration and Implementation of CDISC Standards

October, Integration and Implementation of CDISC Standards Integration and Implementation of CDISC Standards October, 2008 Barbara Lentz, Associate Director, Electronic Data Management Standards, Processes & Training Pat Majcher, Statistical Reporting Services

More information

Professor Ewan Birney FRS Director, EMBL-EBI

Professor Ewan Birney FRS Director, EMBL-EBI Infrastructures for research and innovation Professor Ewan Birney FRS Director, EMBL-EBI www.ebi.ac.uk Outline of talk Who Am I, What is EMBL? The change in genomics The needs for stratified patients in

More information

Our website:

Our website: Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate

More information

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 New Tools for Personalized Medicine *Tools = Assays, Devices, Software Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 http://epigenomics.cemm.oeaw.ac.at http://biomedical-sequencing.at

More information

Personalized Human Genome Sequencing

Personalized Human Genome Sequencing Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome

More information

Q4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery

Q4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery 2018 - Q4 Search The GA4GH Search API enables a search engine for genomic and clinical data by providing specification for query language across genomic, phenotypic, and clinical data that can be used

More information

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.

More information

Dr. Thibaud Mascart. ERA-MBT final conference Oceans of opportunities. Oslo, 20 Nov 2017

Dr. Thibaud Mascart. ERA-MBT final conference Oceans of opportunities. Oslo, 20 Nov 2017 Dr. Thibaud Mascart ERA-MBT final conference Oceans of opportunities Oslo, 20 Nov 2017 Enabling technologies and infrastructure there remains an acute need to continue to build research and innovation

More information

Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen

Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen European Life Sciences Infrastructure for Biological Information www.elixir europe.org ELIXIR connects national bioinformatics centres

More information

Delivering on the promise: the clinical application of new diagnoses and treatments for RD K A T E B U S H B Y N E W C A S T L E U N I V E R S I T Y

Delivering on the promise: the clinical application of new diagnoses and treatments for RD K A T E B U S H B Y N E W C A S T L E U N I V E R S I T Y Delivering on the promise: the clinical application of new diagnoses and treatments for RD K A T E B U S H B Y N E W C A S T L E U N I V E R S I T Y PERSPECTIVE/ DISCLAIMERS Doctor with >24 years experience

More information

WP2 Legal, Governance & Ethical Issues

WP2 Legal, Governance & Ethical Issues WP2 Legal, Governance & Ethical Issues Stakeholder Meeting in Heidelberg 30 January 2012 Co- Chairs Dr. Edvard Beem, ZonMW, NL Dr. Silke Schumacher, EMBL WP2 Deliverables Deliverables by January 2012:

More information

New Frontiers in Personalized Medicine

New Frontiers in Personalized Medicine New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended

More information

Biobanking for the 100,000 genomes project. BBMRI-UKCTC satellite meeting 29 th September

Biobanking for the 100,000 genomes project. BBMRI-UKCTC satellite meeting 29 th September Biobanking for the 100,000 genomes project BBMRI-UKCTC satellite meeting 29 th September The challenge Scale Quality Patient to sample/data to clinician Impact of pre-analytical variables vs cost of process

More information

The EMBL-Bioinformatics and Data-Intensive Informatics

The EMBL-Bioinformatics and Data-Intensive Informatics The EMBL-Bioinformatics and Data-Intensive Informatics Graham Cameron EMBL-EBI What is the EMBL-EBI? Non-profit organization Part of the European Molecular Biology Laboratory Based on the Wellcome Trust

More information

Page 1 of 5 Message from the Director: As the summer kicks off, many of us will renew our focus on research and scholarship. Towards this goal, we draw your attention to a several upcoming events and opportunities

More information

Perspectives on the Priorities for Bioinformatics Education in the 21 st Century

Perspectives on the Priorities for Bioinformatics Education in the 21 st Century Perspectives on the Priorities for Bioinformatics Education in the 21 st Century Oyekanmi Nash, PhD Associate Professor & Director Genetics, Genomics & Bioinformatics National Biotechnology Development

More information

Workshop 2 Getting involved in Research How can patient organizations trigger an EUfunded rare disease project?

Workshop 2 Getting involved in Research How can patient organizations trigger an EUfunded rare disease project? Workshop 2 Getting involved in Research How can patient organizations trigger an EUfunded rare disease project? Contract 036825 The role of patient groups in an EU-project Speaker: Peter Streng Organization:

More information

All research lines at the LMU have a strong methodological focus

All research lines at the LMU have a strong methodological focus Content: Genetic Epidemiology and Statistical Genetics in Complex Diseases... 2 Molecular Epidemiology of Complex Phenotypes... 2 Clinical Trials and Translational Medicine... 3 Clinical Epidemiology and

More information

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date F o r a c l e a r e r m a r k e t p e r s p e c t i v e Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y Report

More information

The Power to Cure: Therapeutic Innovation in Academia

The Power to Cure: Therapeutic Innovation in Academia The Power to Cure: Therapeutic Innovation in Academia Leslie Molony, Ph.D. November 7, 2011 Sanford-Burnham Medical Research Institute: a Non Profit Basic Research Institute Santa Barbara Est. 2006 La

More information

Successful and Faster Drug Development through Data Mining Dirk Belmans, Ph.D. SAS Belgium

Successful and Faster Drug Development through Data Mining Dirk Belmans, Ph.D. SAS Belgium Successful and Faster Drug Development through Data Mining Dirk Belmans, Ph.D. SAS Belgium The Life-Cycle of a Successful Pharmaceutical Product Sales Costs Patent Filing R&D time to launch is decreasing

More information

Fujifilm Diosynth Biotechnologies. General Introduction

Fujifilm Diosynth Biotechnologies. General Introduction Fujifilm Diosynth Biotechnologies General Introduction October 2016 Value from Innovation Safety information Accompanied by FDB staff at all times Fire alarm. Follow host to assembly point Toxic alarm.

More information

CRO partner in Rx/CDx Co-Development

CRO partner in Rx/CDx Co-Development CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics

More information

The Mitochondrial European Educational Training Project (MEET) Funded within the frame of PEOPLE Marie Curie Actions. Presents

The Mitochondrial European Educational Training Project (MEET) Funded within the frame of PEOPLE Marie Curie Actions. Presents The Mitochondrial European Educational Training Project (MEET) Funded within the frame of PEOPLE Marie Curie Actions Presents MEET Symposium 2016 From bench to bedside, and back: Patients MEET Researchers

More information

MRC-NIHR National Phenome Centre

MRC-NIHR National Phenome Centre MRC-NIHR National Phenome Centre PROFESSOR JEREMY NICHOLSON Director of the MRC-NIHR National Phenome Centre OUR PHILOSOPHY Disease risk at the individual and population level is determined by complex

More information

Life science e-infrastructure

Life science e-infrastructure Life science e-infrastructure WORKSHOP 2013 October 10, 2013 Life science e-infrastructure workshop SARA part of the SURF family SURF is the collaborative organization for higher education institutions

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

6th Form Open Day 15th July 2015

6th Form Open Day 15th July 2015 6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine

More information

M a x i m i z in g Value from NGS Analytics in t h e E n terprise

M a x i m i z in g Value from NGS Analytics in t h e E n terprise Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881 www.idc-hi.com M a x i m i z in g Value from NGS Analytics in t h e E n terprise C U S T O M I N D U S T R Y B

More information

How European RIs can boost Open Science & Open Innovation

How European RIs can boost Open Science & Open Innovation How European RIs can boost Open Science & Open Innovation Kurt Zatloukal, Medical University Graz, Austria Corbel Innovation Meeting Brussels, June 20th, 2017 Grant agreement No 654248 Funded by GZ 10.470/0016-II/3/2013

More information